Titre:
  • Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir™ versus continued HAART: The trizal study
Auteur:Lafeuillade, Alain; Clumeck, Nathan; Mallolas, Josep; Jaeger, Hans; Livrozet, Jean-Michel; do Sameira Ferreira, Maria; Johnson, Margaret; Cheret, Arnaud; Antoun, Zeina; Demonty, Jean; Bazin, C.; Bentata, Michelle; Bouvet, Élisabeth; Delfraissy, J.F.; Dellamonica, Pierre; Saint Marc, T.; De Saint Martin, Luc; De Truchis, Pierre; Dien, Georges; Gallais, H.; Gil, Helder; Hoen, Bruno; Katlama, Christine; Lacoste, Denis; Lang, Jeanmarie; Livrozet, Jean-Michel; Beumont, Maria; Massip, P.; Rozenbaum, Willy; Sereni, Daniel; Yeni, Patrick; Fenske, Stefan; Rockstroh, Jürgen; Salzberger, Bernd; Schuermann, D.; Staszewski, Schlomo; Mulcahy, Fiona; Lazzarin, Adriano; Milazzo, Francesco; Moroni, Mauro; Cargnel, Antonietta; Santos, Claudia Paula; Flamholc, Leo; Koppel, Kristina; Easterbrook, Philippa; Fisher, Martin; Gazzard, Brian; Kinghorn, George; Weber, Jonathan; Wilkins, Edmund
Informations sur la publication:HIV clinical trials, 4, 1, page (37-43)
Statut de publication:Publié, 2003-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Lipids
Lipodystrophy
Trizivir™
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1528-4336
info:doi/10.1310/EJRF-JGGH-GRCD-MED8
info:scp/0037226383